Strategic integration creates an end-to-end global CDMO platform with U.S.-Europe supply chain redundancy for pharmaceutical and biotech companies

战略整合为制药和生物技术公司创建了一个端到端的全球CDMO平台，并实现了美欧供应链冗余。

WILMINGTON, N.C.

北卡罗来纳州威尔明顿

,

，

April 21, 2026

2026年4月21日

/PRNewswire/ -- Alcami Corporation ('Alcami'), a leading U.S.-based contract development and manufacturing organization (CDMO), today announced it has entered into a definitive agreement to acquire Tjoapack, a leading global contract packaging organization with facilities in the United States and The Netherlands..

/PRNewswire/ -- 美国领先的合同开发和制造组织（CDMO）Alcami Corporation（“Alcami”）今日宣布，已达成一项最终协议，收购全球领先的合同包装组织Tjoapack，该公司在美国和荷兰设有设施。

Tjoapack has been a trusted supplier of contract primary and secondary packaging solutions for more than 35 years. Their packaging and labeling services include oral solid dose (blister and bottles), sterile injectables (vials, pre-filled syringes and auto-injectors) and kitting. Tjoapack operates from facilities in Clinton, Tennessee and Etten-Leur, The Netherlands with 23 packaging lines and employs over 400 skilled personnel.

Tjoapack 在过去的 35 年多时间里一直是值得信赖的合同初级和二级包装解决方案供应商。他们的包装和标签服务包括口服固体制剂（泡罩和瓶装）、无菌注射剂（小瓶、预充式注射器和自动注射器）以及配套组装。Tjoapack 在美国田纳西州克林顿和荷兰埃滕-勒尔的工厂运营，拥有 23 条包装线，并雇用超过 400 名技术娴熟的员工。

Tjoapack supports more than 40 commercial markets globally with its services..

全球范围内，Tjoapack 的服务覆盖超过40个商业市场。

'This acquisition marks our first European expansion which is an essential element of our investment strategy to expand our presence in the global market,' said Patrick Walsh, Chairman and CEO of Alcami. 'Furthermore, this increased scale aligns with our growth and expansion in pharmaceutical testing lab services, drug product manufacturing and pharma storage service offerings at Alcami.'.

“这次收购标志着我们首次在欧洲的扩张，这是我们扩大在全球市场影响力的投资战略的重要组成部分，”Alcami董事长兼首席执行官Patrick Walsh表示。“此外，这一规模的扩大符合我们在Alcami的制药测试实验室服务、药品生产以及制药存储服务的增长与扩展计划。”

This purchase enables Alcami to offer U.S. supply chain redundancy and scale for packaging and labeling, while adding Qualified Person (QP) release and related services in Europe, allowing customers to expand their global reach from a single supplier. Tjoapack clients will gain access to Alcami's comprehensive services, including pharmaceutical testing labs, sterile and oral solid dose drug product manufacturing and GMP pharma storage, ensuring medicines are delivered worldwide with minimal supplier hand-offs..

此次收购使Alcami能够为包装和标签提供美国供应链的冗余和规模，同时增加欧洲的合格人员（QP）放行及相关服务，使客户能够通过单一供应商扩大其全球覆盖范围。Tjoapack的客户将可以使用Alcami的全面服务，包括药物测试实验室、无菌和口服固体制剂药品生产和符合GMP标准的药品存储，确保药品在全球范围内以最少的供应商交接进行交付。

'This transaction represents an important next chapter for Tjoapack. Partnering with Alcami allows us to accelerate our growth ambitions while staying true to what has made Tjoapack successful—quality, reliability, and a strong focus on our customers,' said Dexter Tjoa, CEO of Tjoapack. 'Together, we create a more integrated transatlantic platform that enables us to support our partners more effectively as they scale and expand globally.'.

“这笔交易代表了Tjoapack重要的新篇章。与Alcami合作使我们能够加速实现我们的增长目标，同时坚持Tjoapack成功的核心——质量、可靠性以及以客户为中心，”Tjoapack首席执行官Dexter Tjoa表示。“通过合作，我们打造了一个更加一体化的跨大西洋平台，能够更有效地支持我们的合作伙伴在全球范围内的扩展。”

The transaction is subject to customary closing conditions and is expected to close in the second quarter of this year.

本次交易受惯例成交条件的约束，预计将在今年第二季度完成。

About Alcami

关于Alcami

Alcami Corporation is a U.S.-based contract development and manufacturing organization headquartered in North Carolina with over 45 years of experience advancing pharmaceuticals and biologics from development to delivery. Alcami provides fully integrated lab services, drug product manufacturing, cGMP pharma storage, and support services.

阿尔卡米公司是一家总部位于美国北卡罗来纳州的合同开发和制造组织，拥有超过45年推动药物和生物制品从开发到交付的经验。阿尔卡米提供完全集成的实验室服务、药品生产、cGMP制药存储及支持服务。

Alcami's private equity ownership includes GHO Capital, The Vistria Group, and Ampersand Capital Partners. For more information, please visit .

Alcami的私募股权所有权包括GHO Capital、The Vistria Group和Ampersand Capital Partners。欲了解更多信息，请访问。

www.alcami.com

www.alcami.com

.

。

About Tjoapack

关于Tjoapack

Tjoapack is a global contract packaging organization (CPO) serving the pharmaceutical and biotechnology industries, with more than 35 years of experience in regulated pharmaceutical packaging. Founded in 1989 and headquartered in The Netherlands, the company operates GMP‑compliant facilities in Europe and the United States, including sites in Etten‑Leur, The Netherlands, and Clinton, Tennessee.

Tjoapack 是一家全球性的合同包装组织 (CPO)，服务于制药和生物技术行业，拥有超过 35 年的受监管制药包装经验。公司成立于 1989 年，总部位于荷兰，在欧洲和美国运营符合 GMP 标准的设施，包括荷兰埃滕-勒尔和美国田纳西州克林顿的工厂。

Private equity healthcare firm Ampersand Capital Partners is the majority owner of Tjoapack. For more information, please visit .

私募股权医疗公司Ampersand Capital Partners是Tjoapack的大股东。欲了解更多信息，请访问。

www.tjoapack.com

www.tjoapack.com

.

。

SOURCE Alcami

源 Alcami

21

21

%

%

more press release views with

更多新闻发布视图与

Request a Demo

请求演示